Defendants failed to acknowledge applying Mandl team's revolutionary platform for COVID-19 vaccine development, leading to GSK's patent infringement complaint.
GSK contends Pfizer and BioNTech developed their vaccines using patented inventions created by the Mandl team a decade earlier, reflected in various U.S. Patent Nos. 11,638,693; 11,638,694; 11,666,534; 11,766,401; and 11,786,467.
[
add
]
[
|
|
...
]